116 related articles for article (PubMed ID: 10522087)
1. [A new antibacterial agent can stop resistance development. Expectations are connected to linezolid, an oxazolidinone with a new pharmacological action].
Sköld O
Lakartidningen; 1999 Sep; 96(37):3866-7. PubMed ID: 10522087
[No Abstract] [Full Text] [Related]
2. Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections.
Brickner SJ; Hutchinson DK; Barbachyn MR; Manninen PR; Ulanowicz DA; Garmon SA; Grega KC; Hendges SK; Toops DS; Ford CW; Zurenko GE
J Med Chem; 1996 Feb; 39(3):673-9. PubMed ID: 8576909
[TBL] [Abstract][Full Text] [Related]
3. An update on the oxazolidinone antibiotics.
Abdel-Rahman SM; Kearns GL
Pediatr Infect Dis J; 1999 Dec; 18(12):1101-2. PubMed ID: 10608633
[No Abstract] [Full Text] [Related]
4. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.
Chien JW; Kucia ML; Salata RA
Clin Infect Dis; 2000 Jan; 30(1):146-51. PubMed ID: 10619743
[TBL] [Abstract][Full Text] [Related]
5. Methicillin-resistant Staphylococcus aureus infection in a renal allograft recipient treated successfully with a novel new antimicrobial agent (linezolid): new treatment options for infections due to resistant organisms.
Antony SJ; Bitter KM; Moreland T; Raudales F; Diaz-Luna H
Clin Infect Dis; 1999 Nov; 29(5):1341-2. PubMed ID: 10524997
[No Abstract] [Full Text] [Related]
6. Linezolid, critical characteristics.
Hamel JC; Stapert D; Moerman JK; Ford CW
Infection; 2000; 28(1):60-4. PubMed ID: 10744479
[No Abstract] [Full Text] [Related]
7. Synthesis of novel tricyclic oxazolidinones by a tandem SN2 and SNAr reaction: SAR studies on conformationally constrained analogues of Linezolid.
Selvakumar N; Yadi Reddy B; Sunil Kumar G; Khera MK; Srinivas D; Sitaram Kumar M; Das J; Iqbal J; Trehan S
Bioorg Med Chem Lett; 2006 Aug; 16(16):4416-9. PubMed ID: 16781153
[TBL] [Abstract][Full Text] [Related]
8. Oxazolidinone structure-activity relationships leading to linezolid.
Barbachyn MR; Ford CW
Angew Chem Int Ed Engl; 2003 May; 42(18):2010-23. PubMed ID: 12746812
[TBL] [Abstract][Full Text] [Related]
9. [Linezolid, an agent from a new class of antibiotics].
Kuijper EJ; Schippers EF; Bernards AT
Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1577-81. PubMed ID: 15382556
[TBL] [Abstract][Full Text] [Related]
10. Oxazolidinones: a review.
Diekema DI; Jones RN
Drugs; 2000 Jan; 59(1):7-16. PubMed ID: 10718097
[TBL] [Abstract][Full Text] [Related]
11. Novel tetrahydro-thieno pyridyl oxazolidinone: an antibacterial agent.
Lohray BB; Lohray VB; Srivastava BK; Kapadnis PB; Pandya P
Bioorg Med Chem; 2004 Sep; 12(17):4557-64. PubMed ID: 15358283
[TBL] [Abstract][Full Text] [Related]
12. [Linezolid, the first oxazolidinone antibiotic].
Dutronc H; Bocquentin F; Galpérine T; Lafarie-Castet S; Dupon M
Med Mal Infect; 2005 Sep; 35(9):427-34. PubMed ID: 16297585
[TBL] [Abstract][Full Text] [Related]
13. A novel antimicrobial agent joins the battle against resistant bacteria.
Moellering RC
Ann Intern Med; 1999 Jan; 130(2):155-7. PubMed ID: 10068364
[No Abstract] [Full Text] [Related]
14. Linezolid resistance in coagulase-negative staphylococci.
Kelly S; Collins J; Davin M; Gowing C; Murphy PG
J Antimicrob Chemother; 2006 Oct; 58(4):898-9; author reply 899-900. PubMed ID: 16854956
[No Abstract] [Full Text] [Related]
15. Linezolid (Zyvox).
Med Lett Drugs Ther; 2000 May; 42(1079):45-6. PubMed ID: 10859730
[No Abstract] [Full Text] [Related]
16. Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives.
Dixit PP; Nair PS; Patil VJ; Jain S; Arora SK; Sinha N
Bioorg Med Chem Lett; 2005 Jun; 15(12):3002-5. PubMed ID: 15908210
[TBL] [Abstract][Full Text] [Related]
17. Recent developments in the discovery of novel oxazolidinone antibacterials.
Gravestock MB
Curr Opin Drug Discov Devel; 2005 Jul; 8(4):469-77. PubMed ID: 16022183
[TBL] [Abstract][Full Text] [Related]
18. [Linezolid, an agent from a new class of antibiotics].
Slebos DJ; Van Altena R
Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2462; author reply 2462-3. PubMed ID: 15626313
[No Abstract] [Full Text] [Related]
19. In vitro susceptibility of staphylococci to linezolid and other antimicrobial agents.
Poiată A; Tuchiluş C; Bădicuţ I; Grigore L; Buiuc D
Roum Arch Microbiol Immunol; 2002; 61(4):293-9. PubMed ID: 15055263
[TBL] [Abstract][Full Text] [Related]
20. Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center.
Kloss P; Xiong L; Shinabarger DL; Mankin AS
J Mol Biol; 1999 Nov; 294(1):93-101. PubMed ID: 10556031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]